| A clinical approach to diagnosis of autoimmune encephalitis F Graus, MJ Titulaer, R Balu, S Benseler, CG Bien, T Cellucci, I Cortese, ... The lancet neurology 15 (4), 391-404, 2016 | 3984 | 2016 |
| Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis J Dalmau, E Lancaster, E Martinez-Hernandez, MR Rosenfeld, ... The Lancet Neurology 10 (1), 63-74, 2011 | 3009 | 2011 |
| CRISPR-engineered T cells in patients with refractory cancer EA Stadtmauer, JA Fraietta, MM Davis, AD Cohen, KL Weber, E Lancaster, ... Science 367 (6481), eaba7365, 2020 | 1349 | 2020 |
| Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series M Lai, MGM Huijbers, E Lancaster, F Graus, L Bataller, R Balice-Gordon, ... The Lancet Neurology 9 (8), 776-785, 2010 | 1239 | 2010 |
| Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen E Lancaster, M Lai, X Peng, E Hughes, R Constantinescu, J Raizer, ... The Lancet Neurology 9 (1), 67-76, 2010 | 1071 | 2010 |
| An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models J Dalmau, T Armangué, J Planagumà, M Radosevic, F Mannara, ... The Lancet Neurology 18 (11), 1045-1057, 2019 | 797 | 2019 |
| B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma AD Cohen, AL Garfall, EA Stadtmauer, JJ Melenhorst, SF Lacey, ... The Journal of clinical investigation 129 (6), 2210-2221, 2019 | 740 | 2019 |
| Neuronal autoantigens—pathogenesis, associated disorders and antibody testing E Lancaster, J Dalmau Nature Reviews Neurology 8 (7), 380-390, 2012 | 652 | 2012 |
| Encephalitis and antibodies to synaptic and neuronal cell surface proteins E Lancaster, E Martinez-Hernandez, J Dalmau Neurology 77 (2), 179-189, 2011 | 559 | 2011 |
| The diagnosis and treatment of autoimmune encephalitis E Lancaster Journal of Clinical Neurology 12 (1), 1-13, 2016 | 528 | 2016 |
| Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia E Lancaster, MGM Huijbers, V Bar, A Boronat, A Wong, ... Annals of neurology 69 (2), 303-311, 2011 | 514 | 2011 |
| The clinical spectrum of Caspr2 antibody–associated disease A van Sonderen, H Ariño, M Petit-Pedrol, F Leypoldt, P Körtvélyessy, ... Neurology 87 (5), 521-528, 2016 | 452 | 2016 |
| Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome E Lancaster, E Martinez-Hernandez, MJ Titulaer, M Boulos, S Weaver, ... Neurology 77 (18), 1698-1701, 2011 | 382 | 2011 |
| Anti-LGI1–associated cognitive impairment: presentation and long-term outcome H Ariño, T Armangué, M Petit-Pedrol, L Sabater, E Martinez-Hernandez, ... Neurology 87 (8), 759-765, 2016 | 352 | 2016 |
| A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis R Balu, L McCracken, E Lancaster, F Graus, J Dalmau, MJ Titulaer Neurology 92 (3), e244-e252, 2019 | 276 | 2019 |
| Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype A McKeon, E Martinez-Hernandez, E Lancaster, JY Matsumoto, ... JAMA neurology 70 (1), 44-50, 2013 | 252 | 2013 |
| Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects TE Schlaepfer, EC Strain, BD Greenberg, KL Preston, E Lancaster, ... American Journal of Psychiatry 155 (4), 470-473, 1998 | 184 | 1998 |
| Clinical and immunologic investigations in patients with stiff-person spectrum disorder E Martinez-Hernandez, H Ariño, A McKeon, T Iizuka, MJ Titulaer, ... JAMA neurology 73 (6), 714-720, 2016 | 171 | 2016 |
| Paraneoplastic disorders in thymoma patients A Evoli, E Lancaster Journal of Thoracic Oncology 9 (9), S143-S147, 2014 | 155 | 2014 |
| Brain changes in schizophrenia: volumetric MRI study of families multiply affected with schizophrenia–the Maudsley Family Study 5 T Sharma, E Lancaster, D Lee, S Lewis, T Sigmundsson, N Takei, ... The British Journal of Psychiatry 173 (2), 132-138, 1998 | 143 | 1998 |
